Day: July 19, 2025
Ipilimumab (YERVOY®) Agent Description Ipilimumab is a recombinant, human monoclonal antibody that binds to the cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Ipilimumab is an IgG1 kappa immunoglobulin with an approximate molecular weight of 148 kDa. Mechanism of Action CTLA-4 is a negative regulator of T-cell activity.

